<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Pagh Greenwood | Activity</title>
	<link>https://recash.wpsoul.net/members/iriswrist71/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/iriswrist71/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Pagh Greenwood.</description>
	<lastBuildDate>Fri, 15 May 2026 20:08:21 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">50725f1f4b617e30366bbff50a416f83</guid>
				<title>Pagh Greenwood posted an update: Successful integration of nanotechnology into the current [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/55908/</link>
				<pubDate>Wed, 11 Dec 2024 22:55:00 +0000</pubDate>

									<content:encoded><![CDATA[<p>Successful integration of nanotechnology into the current paradigm of cancer therapy requires proper understanding of the interface between nanoparticles (NPs) and cancer cells, as well as other key components within the tumor microenvironment (TME), such as normal fibroblasts (FBs) and cancer-associated FBs (CAFs). So far, much focus has been on&hellip;<span class="activity-read-more" id="activity-read-more-55908"><a href="https://recash.wpsoul.net/activity/p/55908/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d41d4d4f2df9e21f815cfb6268f83dd1</guid>
				<title>Pagh Greenwood became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/55683/</link>
				<pubDate>Wed, 11 Dec 2024 22:39:14 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>